{"changes":[],"country":"US","description":"Protego Biopharma develops small-molecule pharmacological chaperones that restore proper protein folding to treat protein misfolding diseases. It targets patients with conditions including cardiomyopathy and AL amyloidosis. The company was built on the success of tafamidis, an FDA-approved amyloidosis treatment discovered by its cofounders.","domain":"protegobio.com","employees":null,"founded":2020,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"bio","investors":[],"lat":39.78373,"lng":-100.445882,"location":"USA","name":"Protego Biopharma","rounds":[{"amountQuarantined":false,"amountUsd":130000000,"currency":"USD","date":"2025-12-01","investors":[],"leadInvestor":null,"source":{"fact":"round","publisher":"crunchbase","retrievedAt":"2026-05-07","status":"attributed","url":null},"status":"attributed","type":"series-d+","url":null}],"slug":"protegobio-com","sources":[{"fact":"round","publisher":"crunchbase","retrievedAt":"2026-05-07","status":"attributed","url":null},{"fact":"existence","publisher":"protegobio.com","retrievedAt":"2026-05-07","status":"self-reported","url":"https://protegobio.com"},{"fact":"description","publisher":"protegobio.com","retrievedAt":"2026-05-07","status":"self-reported","url":"https://protegobio.com"}],"stage":"series-b+","techStack":["Apache HTTP Server","apache"],"totalRaisedUsd":130000000,"updatedAt":"2026-05-07"}